Fogt F, Zhuang Z, Poremba C, Dockhorn-Dworniczak B, Vortmeyer A
University of Pennsylvania, Presbyterian Medical Center, Department of Pathology, 39th and Market Street, Philadelphia, PA 19104, USA.
Oncol Rep. 1998 Mar-Apr;5(2):477-80. doi: 10.3892/or.5.2.477.
We correlated p53 overexpression with allelic deletion of p53 in ulcerative colitis (UC) with high grade dysplasia (HGD, n=12) and carcinoma (CA, n=8). Sections were immunostained against p53 and epithelium was microdissected on consecutive sections with subsequent amplification for LOH of p53 (17p). Staining with anti-p53 was positive in HGD (9 of 12) and CA (7 of 8). Percent positive cells were less in HGD than in CA. LOH of p53 was present in HGD (5 of 12) and CA (5 of 7). Of cases with <10% of positive cells, including negative cases, 50% also showed LOH. These results suggest that most cases with prominent p53 overexpression but also significant numbers of cases with weak or negative expression have associated allelic p53 deletion. We conclude that i) immunohistochemical stains but not LOH for p53 correlate with progression of dysplasia to carcinoma, ii) p53 immunohistochemistry appears to more accurately predict biologic behavior of dysplasia and carcinoma in UC compared to allelic deletion studies alone. Further microdissection studies are necessary to evaluate the possibility of different carcinoma risk in patients with low percentage of p53 overexpression and associated LOH.
我们将p53过表达与溃疡性结肠炎(UC)伴高级别异型增生(HGD,n = 12)和癌(CA,n = 8)中p53的等位基因缺失进行了关联分析。对切片进行p53免疫染色,并在连续切片上对上皮进行显微切割,随后对p53(17p)的杂合性缺失(LOH)进行扩增。抗p53染色在HGD(12例中的9例)和CA(8例中的7例)中呈阳性。HGD中阳性细胞百分比低于CA。p53的LOH存在于HGD(12例中的5例)和CA(7例中的5例)中。在阳性细胞<10%的病例中,包括阴性病例,50%也显示出LOH。这些结果表明,大多数p53过表达显著的病例,但也有相当数量的弱表达或阴性表达病例存在等位基因p53缺失。我们得出结论:i)p53的免疫组化染色而非LOH与异型增生向癌的进展相关;ii)与单独的等位基因缺失研究相比,p53免疫组化似乎能更准确地预测UC中异型增生和癌的生物学行为。有必要进行进一步的显微切割研究,以评估p53过表达百分比低且伴有LOH的患者发生不同癌症风险的可能性。